Autonomix Medical宣布其关于胰腺癌疼痛管理的长期数据研究摘要,已获欧洲介入心脏病学年会2026的正式接受。这一进展将有助于在业界顶级会议上展示该公司的研究成果。
Autonomix Medical宣布其关于胰腺癌疼痛管理的长期数据研究摘要,已获欧洲介入心脏病学年会2026的正式接受。这一进展将有助于在业界顶级会议上展示该公司的研究成果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.